Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 40 of about 62 companies and 74 funds for Mark Jackson
Company Exchange Symbol Last price Quote change Market cap
Breitburn Energy Partners LP OTCMKTS BBEPQ 0.0665 -0.0050 (-6.97%) 14.22M
Breitburn Energy Partners LP is an independent oil and gas partnership focused on the acquisition, exploitation and development of oil, natural gas liquid ...
Executive:
Mark L. Pease
Flowserve Corp NYSE FLS 47.36 -0.32 (-0.67%) 6.20B
Flowserve Corporation is a manufacturer and aftermarket service provider of flow control systems. The Company operates through three segments: Engineered ...
Executive:
Mark A. Blinn
Molycorp Inc OTCMKTS MCPIQ 0.0345 +0.0001 (0.14%) 8.96M
Molycorp, Inc. is a rare earths producer. The Company operates in four business segments: Resources, Chemicals and Oxides, Magnetic Materials and Alloys and ...
Executive:
Mark S Kristoff
Rent-A-Center Inc NASDAQ RCII 13.20 +0.45 (3.53%) 703.57M
Rent-A-Center, Inc. is a rent-to-own operator in North America. The Company provides an opportunity to obtain ownership of products, such as consumer ...
Executive:
Mark E. Denman
JMP Group Inc. NYSE JMP 5.45 -0.10 (-1.81%) 114.47M
JMP Group, Inc. is a full-service investment banking and asset management firm. The Company operates in five segments: Broker-Dealer, Asset Management, ...
Executive:
H. Mark Lunenburg
Rexnord Corp NYSE RXN 21.14 -0.07 (-0.33%) 2.15B
Rexnord Corporation is a multi-platform industrial company. The Company operates through two segments: Process & Motion Control platform, ...
Executive:
Mark S. Bartlett
Tandy Leather Factory, Inc. NASDAQ TLF 7.16 -0.04 (-0.56%) 66.11M
Tandy Leather Factory, Inc. is a retailer and a wholesale distributor of a range of leather and related products. The Company's products include leather, ...
Executive:
Mark J. Angus
AstraZeneca plc (ADR) NYSE AZN 31.15 +0.02 (0.06%) 78.75B
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription ...
Executive:
Mark Mallon
Cascadian Therapeutics Inc (USA) NASDAQ CASC 1.14 0.00 (0.00%) 148.16M
Cascadian Therapeutics, Inc., formerly Oncothyreon Inc., is a clinical-stage biopharmaceutical company. The Company focuses on the development of ...
Executive:
Mark Lampert
Qlik Technologies Inc NASDAQ QLIK 30.06 0.00 (0.00%) 2.83B
Qlik Technologies Inc. (Qlik) is a provider of user-driven Business Intelligence (BI) solutions that enable its customers to make informed business ...
Executive:
Mark C Thurmond
Echostar Corporation NASDAQ SATS 38.94 -0.26 (-0.66%) 3.68B
EchoStar Corporation is a holding company. The Company operates through three segments: Hughes, EchoStar Technologies (ETC) and EchoStar Satellite Services ...
Executive:
Mark W.
Constellation Brands, Inc. NYSE STZ 166.32 -1.34 (-0.80%) 33.76B
Constellation Brands, Inc. is an international beverage alcohol company. The Company is a producer and marketer of beer and wine the United States and ...
AMN Healthcare Services, Inc. NYSE AHS 43.84 -0.03 (-0.07%) 2.11B
AMN Healthcare Services, Inc. (AMN Healthcare) offers healthcare workforce solutions and staffing services to healthcare facilities.
Executive:
Mark G. Foletta CPA
AstraZeneca plc LON AZN 4,650.93 +38.43 (0.83%) 59.38B
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription ...
Executive:
Mark Mallon
Duluth Metals Ltd TSE DM 0.445 63.14M
Duluth Metals Limited is a Canada-based mineral exploration company. It is engaged in developing the Twin Metals Minnesota (TMM) ...
Executive:
Mark D.
Ryman Hospitality Properties Inc NYSE GET 39.53 2.00B
Ryman Hospitality Properties, Inc. is a self-advised and self-administered real estate investment trust (REIT). The Company's segments include Hospitality, ...
Executive:
Mark Fioravanti
Manhattan Bridge Capital Inc. NASDAQ LOAN 5.47 -0.10 (-1.80%) 40.87M
Manhattan Bridge Capital, Inc. (MBC) is a real estate finance company that specializes in originating, servicing and managing a portfolio of first mortgage ...
Executive:
Mark Alhadeff
Constellation Brands, Inc. NYSE STZ.B 165.87 0.00 (0.00%) 33.58B
Constellation Brands, Inc. is an international beverage alcohol company. The Company is a producer and marketer of beer and wine the United States and ...
Calamos Conv. Opptys. & Income Fund NASDAQ CHI 10.39 -0.08 (-0.76%) 729.36M
Calamos Convertible Opportunities and Income Fund is a fixed income fund. The Fund seeks total return through capital appreciation and current income by ...
Executive:
Mark J. Mickey
Great-West Lifeco Inc. TSE GWO 34.32 +0.12 (0.35%) 34.13B
Great-West Lifeco Inc. (Lifeco) is a financial services holding company. The Company has interests in the life insurance, health insurance, asset management ...
Executive:
Seguard Mark Corbett
Show all 62 companies »
Mutual Fund Symbol Nav Nav change
Investors Canadian Balanced A IGI326 14.22 +0.07 (0.46%)
The investment objective of the fund is to achieve a high level of total return (income and capital appreciation) by investing in varying proportions in ...
Executive:
Mark Jackson
Investors Canadian Equity Income Fund A IGI489 12.67 +0.06 (0.45%)
The Fund aims to provide a high level of current income while offering the potential for moderate capital appreciation by investing primarily in Canadian ...
Executive:
Mark Jackson.
Investors Canadian Equity Income Fund B IGI490 12.54 +0.06 (0.44%)
The Fund aims to provide a high level of current income while offering the potential for moderate capital appreciation by investing primarily in Canadian ...
Executive:
Mark Jackson.
JPMorgan Core Plus Bond Fund Class B OINBX 8.33 +0.03 (0.36%)
The investment seeks a high level of current income by investing primarily in a diversified portfolio of high-, medium- and low-grade debt securities.
Executive:
Mark M. Jackson
Investors Canadian Equity Income Fund C IGI515 10.47 +0.06 (0.54%)
The Fund aims to provide a high level of current income while offering the potential for moderate capital appreciation by investing primarily in Canadian ...
Executive:
Mark Jackson.
Investors Canadian Balanced C IGI052 13.76 +0.03 (0.25%)
The investment objective of the fund is to achieve a high level of total return (income and capital appreciation) by investing in varying proportions in ...
Executive:
Mark Jackson
Investors Canadian Balanced B IGI418 14.05 +0.06 (0.46%)
The investment objective of the fund is to achieve a high level of total return (income and capital appreciation) by investing in varying proportions in ...
Executive:
Mark Jackson
Investors Canadian Growth A IGI531 11.54 +0.08 (0.68%)
The Fund aims to provide long-term capital growth by investing primarily in the Canadian equity markets.
Executive:
Mark Jackson.
Investors Canadian Growth C IGI529 11.26 +0.06 (0.56%)
The Fund aims to provide long-term capital growth by investing primarily in the Canadian equity markets.
Executive:
Mark Jackson.
Investors Canadian Growth Class A IGI537 10.51 +0.06 (0.58%)
The Fund aims to provide long-term capital growth by investing primarily in the Canadian equity markets.
Executive:
Mark Jackson.
Investors Canadian Balanced TU IGI1289 10.89 +0.02 (0.17%)
The investment objective of the fund is to achieve a high level of total return (income and capital appreciation) by investing in varying proportions in ...
Executive:
Mark Jackson
Investors Canadian Balanced TC IGI881 9.82 +0.03 (0.34%)
The investment objective of the fund is to achieve a high level of total return (income and capital appreciation) by investing in varying proportions in ...
Executive:
Mark Jackson
CDSPI Global Real Estate Fund (Invesco) CDSP_GLOB_REAL_1QFIIS0 18.43 +0.30 (1.67%)
Seeks to generate a total return through capital growth and income by investing primarily in real estate securities from around the world.
Executive:
Mark D. Blackburn
JNL Multi-Manager Alternative Fund Class A JNL_MULT_ALTE_17O31LV 9.54 +0.02 (0.21%)
The investment seeks long-term growth of capital. The fund seeks to achieve its investment objective by allocating among a variety of alternative strategies ...
Executive:
Mark Landecker
Investors Canadian Growth Class B IGI538 10.39 +0.07 (0.66%)
The Fund aims to provide long-term capital growth by investing primarily in the Canadian equity markets.
Executive:
Mark Jackson.
Investors Canadian Growth B IGI532 11.39 +0.08 (0.68%)
The Fund aims to provide long-term capital growth by investing primarily in the Canadian equity markets.
Executive:
Mark Jackson.
Investors Canadian Equity Income J DSC IGI992 10.24 +0.05 (0.45%)
The Fund aims to provide a high level of current income while offering the potential for moderate capital appreciation by investing primarily in Canadian ...
Executive:
Mark Jackson.
Investors Canadian Balanced TJ NL IGI1170 9.96 +0.05 (0.46%)
The investment objective of the fund is to achieve a high level of total return (income and capital appreciation) by investing in varying proportions in ...
Executive:
Mark Jackson
Investors Canadian Balanced TJ DSC IGI1169 9.95 +0.05 (0.46%)
The investment objective of the fund is to achieve a high level of total return (income and capital appreciation) by investing in varying proportions in ...
Executive:
Mark Jackson
Investors Canadian Growth Ser J NL IGI999 11.35 +0.08 (0.68%)
The Fund aims to provide long-term capital growth by investing primarily in the Canadian equity markets.
Executive:
Mark Jackson.
Show all 74 funds »